EMZOR PHARMACEUTICAL INDUSTRIES LIM
Status: Completed investmentWhy disclosure?
FMO is committed to making publicly available relevant investment information that informs stakeholders and enables them to engage directly with FMO on its investments which, in turn, enhances our investment decisions, the design and implementation of projects and policies, and strengthens development outcomes. Learn more
In case of questions
In case of questions, please contact us at disclosure@fmo.nl
Disclaimer
The information as disclosed is indicative and provided on an "as-is/as available" basis for general informational purposes only and should not be construed as financial, legal or investment advice, nor as a commitment or an offer to arrange or provide any financing. The final decision to provide financing is subject to the terms and conditions of FMO in its sole and absolute discretion. When providing links to other sites, FMO bears no responsibility for the accuracy, legality or content of the external site or for that of subsequent links. The information on proposed investment for high-risk investments is made available in the language relevant to the country or region where the bulk of operations take place. Translations of any information into languages other than English are intended as a convenience for local stakeholders. In case of any discrepancy, the information provided in English will prevail.
Who is our customer
Emzor Pharmaceutical Industries Ltd is a private pharmaceutical manufacturing company based in Lagos, Nigeria specializing in manufacturing high quality pharmaceutical products and medical consumables.
What is our funding objective?
Emzor has developed some procedures to manage drugs and medicine quality, however, gaps with regard to IFC PS1(Assessment and Management of Environmental and Social Risks and Impacts) were identified.
Why do we fund this investment?
Despite the commitment towards good E&S practices, Emzor does not currently have in place an ESMS which would allow the company to manage the E&S risks to the extend desirable by itself and its investors.
- Region
- Africa
- Country
- Nigeria
- Sector
- Infrastructure, Manufacturing and Services
- Effective date
- 9/26/2018
- End date
- 8/20/2021
- Total FMO financing
- EUR 0.01 MLN
- Funding
- FMO NV